Curaleaf International is proud to announce its official partnership as a founding member of a groundbreaking task force aimed at positioning the UK as a global leader in cannabis and cannabinoid research.
This pioneering initiative, led by George Freeman MP and Professor Trevor Jones, will unite universities, research institutions, investors, businesses, and the NHS to advance the understanding of cannabis.
The newly established UK Cannabinoid Research and Development Group (CRDG) is set to develop the country’s first comprehensive cannabinoid R&D strategy, addressing a significant gap that has persisted since cannabis was rescheduled for medical use in 2018. Notably, the UK currently has only three licensed cannabis-based medicines available.
With support from industry partners, including Curaleaf International, the task force will consult on its plans and release its initial strategy paper in July. The group will be officially constituted this summer.
Find out more at crdg.uk
